BC

Boxer Capital Portfolio holdings

AUM $2.04B
This Quarter Return
+2.62%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$2.86B
AUM Growth
+$2.86B
Cap. Flow
+$148M
Cap. Flow %
5.18%
Top 10 Hldgs %
48.6%
Holding
107
New
11
Increased
2
Reduced
2
Closed
19

Top Buys

1
TYRA icon
Tyra Biosciences
TYRA
$111M
2
TNGX icon
Tango Therapeutics
TNGX
$88.9M
3
BPMC
Blueprint Medicines
BPMC
$43.7M
4
FULC icon
Fulcrum Therapeutics
FULC
$35.3M
5
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
$34.9M

Top Sells

1
SGEN
Seagen Inc. Common Stock
SGEN
$63.2M
2
AMRN
Amarin Corp
AMRN
$26.3M
3
KDMN
Kadmon Holdings, Inc.
KDMN
$24M
4
AGEN
Agenus
AGEN
$22M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
$20.9M

Sector Composition

1 Healthcare 98.16%
2 Financials 0.75%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MRTX
1
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$354M 12.36% 2,000,000 – –
ONC
2
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
$277M 9.69% 764,188 – –
SWTX
3
DELISTED
SpringWorks Therapeutics
SWTX
$132M 4.6% 2,075,905 – –
ITOS icon
4
iTeos Therapeutics
ITOS
$117M 4.1% 4,345,016 – –
TYRA icon
5
Tyra Biosciences
TYRA
$675M
$111M 3.88% +6,323,359 New +$111M
RVMD icon
6
Revolution Medicines
RVMD
$7.1B
$95.9M 3.35% 3,484,264 – –
TNGX icon
7
Tango Therapeutics
TNGX
$747M
$88.9M 3.1% +6,871,642 New +$88.9M
CYTK icon
8
Cytokinetics
CYTK
$4.23B
$75.1M 2.62% 2,100,000 – –
RCUS icon
9
Arcus Biosciences
RCUS
$1.13B
$72.7M 2.54% 2,084,883 – –
PMVP icon
10
PMV Pharmaceuticals
PMVP
$74.2M
$67.6M 2.36% 2,268,236 – –
IDYA icon
11
IDEAYA Biosciences
IDYA
$2.15B
$56.2M 1.96% 2,202,812 – –
ARGX icon
12
argenx
ARGX
$43.6B
$51.6M 1.8% 170,926 – –
CNTB
13
Connect Biopharma
CNTB
$115M
$50.4M 1.76% 2,081,323 – –
SAGE
14
DELISTED
Sage Therapeutics
SAGE
$48.5M 1.69% 1,094,000 – –
RCKT icon
15
Rocket Pharmaceuticals
RCKT
$354M
$43.8M 1.53% 1,466,051 – –
SNDX icon
16
Syndax Pharmaceuticals
SNDX
$1.41B
$43.7M 1.53% 2,287,782 – –
BPMC
17
DELISTED
Blueprint Medicines
BPMC
$43.7M 1.53% +425,000 New +$43.7M
NUVB icon
18
Nuvation Bio
NUVB
$1.02B
$43.2M 1.51% 4,341,009 – –
KNTE
19
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$42.5M 1.49% 1,847,559 +781,620 +73% +$18M
MRUS icon
20
Merus
MRUS
$4.98B
$41.8M 1.46% 1,900,000 – –
RLAY icon
21
Relay Therapeutics
RLAY
$619M
$40.8M 1.42% 1,294,132 – –
DBVT
22
DBV Technologies
DBVT
$264M
$36.9M 1.29% 7,534,598 – –
NRIX icon
23
Nurix Therapeutics
NRIX
$714M
$36.7M 1.28% 1,224,892 – –
FULC icon
24
Fulcrum Therapeutics
FULC
$351M
$35.3M 1.23% +1,250,000 New +$35.3M
ANAB icon
25
AnaptysBio
ANAB
$569M
$35.3M 1.23% 1,300,000 – –
1
2 3 4 5